Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
about
Fibrinogen concentrate in bleeding patientsThrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusionThe effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysisAcquired hypofibrinogenemia: current perspectivesThromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.[Management of complex thrombocytopenia with thrombelastometry : a case of simultaneous posttransfusion purpura and heparin-induced thrombocytopenia].Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass.Factor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit.Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest.Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair.Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrateComparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®).Introduction to haemostasis from a pharmacodynamic perspectiveTransfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot StudyFIBTEM provides early prediction of massive transfusion in traumaActive Bleeding after Cardiac Surgery: A Prospective Observational Multicenter StudyRandomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial.The Impact of a Blood Conservation Program in Complex Aortic Surgery.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrestRandomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapyEffect of haematocrit on fibrin-based clot firmness in the FIBTEM test.Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen: A Retrospective Observational Study.The effect of hyperglycemia on blood coagulation: In vitro, observational healthy-volunteer study using rotational thromboelastometry (ROTEM).Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery.The coagulopathy of cardiopulmonary bypass.Fibrinogen concentrates for bleeding trauma patients: what is the evidence?Monitoring patients at risk of massive transfusion with Thrombelastography or Thromboelastometry: a systematic review.Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults.Emerging treatment strategies for trauma-induced coagulopathy.The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.Blood utilization in neonates and infants undergoing cardiac surgery requiring cardiopulmonary bypass.Hemostatic disorders in women.Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.Coagulation and the surgical neonate.
P2860
Q24200171-5431A931-0E21-40FD-9119-9B817B2684AEQ24235742-B9B2A8F6-83B8-4095-B55A-2F9C8563ABF5Q27016555-8D6FB251-B93F-4228-813C-585B5124FDFAQ28077374-6939E21C-A80C-4984-8182-C77B3D9AF727Q30248341-98907061-CD01-49BB-B0D5-102AFE499E63Q33159278-BB23A810-C155-497D-BF9C-8F192052AB46Q33423408-2AF3FBE5-4257-4B02-856B-2254B3B91370Q33441826-8F3D4391-981C-4FDF-A829-930B11AD0EBCQ33677370-2DF283FC-4D29-407F-A09E-ADA96FC855D7Q33793633-025E2742-CABF-4FE3-90E3-BFFD7FC8A2D1Q33795260-35EF8AE9-4A8B-43EC-8E6B-758DD561F4ADQ33919203-3407A619-4117-4AF1-BF82-F5D70783B49EQ35318068-A8D48FC5-87EA-416E-9DA3-04D36F799BEDQ35373597-57368A0A-D508-4448-B762-6ED95995CFB2Q35559379-A92BFC62-FD89-42BC-A541-2B70F8C8904EQ35908250-0FE94797-4CFA-463E-BA4A-F6A3871A8903Q35998338-32385F9A-668A-40B9-9655-210AF619A5ABQ36073037-E05FF9C9-7D6F-41E0-A5BD-C49C50300327Q36121480-5DE91FBF-46F7-4C56-B2A0-398EF8D41F8EQ36142046-D0E893FE-8826-4E04-A4E5-FA0FF4AFA1B3Q36209630-6B4463E5-2425-4B4E-9DBD-E3F9FF129A7BQ36380834-32BFB5EC-C543-4C07-8881-951CA7AAEE01Q36515685-FCE52CCB-CD1B-4185-9F00-96B5BD3E1611Q36916363-ADFE6C11-276C-4D1E-830F-CEF341146922Q37019701-1AB9875C-7531-4AC8-A8F8-8C853E1CEA02Q37059236-BBDE8BA0-3475-4602-B948-8753E08A7774Q37097789-007FBCDA-27D7-4F58-BE71-2A5AE75553BEQ37226343-A7F4DE1E-AC58-4BF9-AB0C-E094CF14ACE0Q37813802-A9C87C55-45AA-4D4D-AAD1-02749B2A3882Q37851496-84A61649-ED2F-44F0-9DA5-C4DCC3BF3B3AQ37871067-DA147FEE-C451-4FCE-88F9-D8B1ACCFBC5AQ37957187-AD6F52AB-3F38-4971-A85F-98CCE1AB696BQ37965826-722F44C5-C3C8-4358-A58C-2C8905EC8E83Q37996341-D9A296B3-A8AB-4744-88D5-B47D7F2B9506Q38072765-767E5427-56BE-4ADB-B753-1C9C83AC14A1Q38115586-B9224154-170E-4DB4-BA72-1298D36FA46CQ38117257-8EEA8FD5-DBBE-4B79-8037-DF15C4CD9B9AQ38117734-41E13064-9423-41F1-AFDD-A728C73A3929Q38151867-7042E149-8318-4308-B715-3730E5783AEFQ38163073-F4F6540F-2BD8-4901-9849-3A43E43FE0CD
P2860
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@en
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@nl
type
label
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@en
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@nl
prefLabel
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@en
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@nl
P2093
P1476
Thromboelastometry-guided admi ...... minal aortic aneurysm surgery.
@en
P2093
Cristina Solomon
Kenichi Tanaka
Maximilian Pichlmaier
Michael Winterhalter
Niels Rahe-Meyer
Siegfried Piepenbrock
P304
P356
10.1016/J.JTCVS.2008.11.065
P407
P577
2009-05-17T00:00:00Z